BIO funding rate on Hyperliquid
Over the last 30 days, BIO funding on Hyperliquid averaged +15.4% APR and stayed positive 99.4% of the time, ranging from -34.9% to +343.7%. Right now it pays longs pay shorts at +10.9% APR, settled every 1h across 5 venues we track. The most reliable delta-neutral pairing for BIO right now is long Aster / short Hyperliquid at +6.1% net APR (medium risk, ~6.9d to break even).
BIO funding history on Hyperliquidlast 30d
- Backtested (30d)
- -5.6%
- Stability
- 67%
- Risk
- medium
- Breakeven
- ~6.9d
Ranked by 30-day reliability (backtest × stability × risk) — the spread that holds, not just the widest current rate.
Open this tradeNot ready to trade? Get a Telegram ping when BIO's delta-neutral funding APR spikes — no sign-up, no wallet needed. The bot confirms your exact watch level.
How BIO funding compares across venues
| Exchange | Funding APR |
|---|---|
| Hyperliquid | +10.95% |
| Variational | +10.95% |
| Lighter | +10.51% |
| Aster | -10.86% |
| Kraken | -233.46% |
Frequently asked
What is the current BIO funding rate on Hyperliquid?
BIO on Hyperliquid is funding at 10.95% APR (0.0013% every 1h), paid longs pay shorts, as of 2026-09-12 15:20 UTC.
How often does Hyperliquid pay funding on BIO?
Every 1 hour.
How do I earn BIO funding without price risk?
Open a delta-neutral position: long Aster and short Hyperliquid, currently 6.1% net APR (medium risk). The two legs cancel price exposure so you keep the funding spread.